Answers are grounded in this paper and cite their sources.
The allylpalladium [Pd(η 3 -C 3 H 5 )(L)](BF 4 ) (L = L 1 ( 1 ), L 2 ( 2 ), L 3 ( 3 ), L 4 ( 4 )) complexes with pyridylpyrazole ligands 2-(5-phenyl-1 H -pyrazol-3-yl)pyridine (L 1 ), 2-(1-ethyl-5-phenyl-1 H -pyrazol-3-yl)pyridine (L 2 ), 2-(1-octyl-5-phenyl)-1 H -pyrazol-3-yl)pyridine (L 3 ), and 2-(5-phenyl-3-(pyridin-2-yl)pyrazol-1-yl)ethanol (L 4 ) were synthesized from the appropriate pyridylpyrazole ligand and [Pd(η 3 -C 3 H 5 )Cl] 2 in the presence of AgBF 4 . The cationic complex 1 was converted into the neutral complex 5 under basic conditions. These complexes were characterized, and the crystal and molecular structure of [Pd(η 3 -C 3 H 5 )(L 2 )](BF 4 ) ( 2 ) was resolved by X-ray diffraction. Also, we have studied the apparent allyl rotation, observed as H syn −H syn and H anti −H anti interconversions. The influences of the solvent, the traces of water, and the N1 substituent have also been studied.
No takes yet. Share an insight, caveat, or question.
Montoya et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: